These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 9436662

  • 1. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO.
    Hum Reprod; 1997 Nov; 12(11):2347-57. PubMed ID: 9436662
    [Abstract] [Full Text] [Related]

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 3. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.
    Contraception; 1997 Sep 11; 56(3):141-6. PubMed ID: 9347203
    [Abstract] [Full Text] [Related]

  • 4. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR, Ory H.
    Contraception; 1997 May 11; 55(5):267-72. PubMed ID: 9220222
    [Abstract] [Full Text] [Related]

  • 5. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO.
    Am J Obstet Gynecol; 1998 Sep 11; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [Abstract] [Full Text] [Related]

  • 6. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
    de Vries CS, van den Berg PB, de Jong-van den Berg LT.
    Contraception; 1998 Apr 11; 57(4):247-9. PubMed ID: 9649916
    [Abstract] [Full Text] [Related]

  • 7. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ.
    Contraception; 1998 Feb 11; 57(2):67-70. PubMed ID: 9589831
    [Abstract] [Full Text] [Related]

  • 8. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep 11; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 9. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.
    Skjeldestad FE.
    Contraception; 1997 Jan 11; 55(1):11-4. PubMed ID: 9013055
    [Abstract] [Full Text] [Related]

  • 10. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O.
    Am J Obstet Gynecol; 1999 Jun 11; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [Abstract] [Full Text] [Related]

  • 11. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Schwingl PJ, Shelton J.
    Contraception; 1997 Mar 11; 55(3):125-9. PubMed ID: 9114999
    [Abstract] [Full Text] [Related]

  • 12. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
    Spitzer WO.
    Br J Clin Pharmacol; 1996 May 11; 41(5):359-63. PubMed ID: 8735675
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD, Lawrenson RA.
    Am J Obstet Gynecol; 1998 Sep 11; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [Abstract] [Full Text] [Related]

  • 14. Modern oral contraceptives and cardiovascular disease.
    Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.
    Am J Obstet Gynecol; 1997 Sep 11; 177(3):707-15. PubMed ID: 9322646
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making?
    Westhoff CL.
    Contraception; 1996 Jul 11; 54(1):1-3. PubMed ID: 8804800
    [Abstract] [Full Text] [Related]

  • 16. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H, Norpoth T, Michaels MA.
    Eur J Contracept Reprod Health Care; 1996 Jul 11; 1(1):21-30. PubMed ID: 9678134
    [Abstract] [Full Text] [Related]

  • 17. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.
    BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491
    [Abstract] [Full Text] [Related]

  • 18. Another pill scare -- should we audit its impact?
    Bromham DR.
    Audit Unit News; 1996 Jan 06; 1(4):2-3. PubMed ID: 12346948
    [Abstract] [Full Text] [Related]

  • 19. Oral contraceptives and cardiovascular outcomes: cause or bias?
    Spitzer WO.
    Contraception; 2000 Aug 06; 62(2 Suppl):3S-9S; discussion 37S-38S. PubMed ID: 11102597
    [Abstract] [Full Text] [Related]

  • 20. Third-generation oral contraceptives: how risky?
    Weiss N.
    Lancet; 1995 Dec 16; 346(8990):1570. PubMed ID: 7500743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.